COMMUNIQUÉS West-GlobeNewswire

Dynavax Reports Second Quarter 2018 Financial Results
06/08/2018
HEPLISAV-B® Launch Progressing as Planned with Key Customer Successes Three abstracts accepted for presentation at European Society for Medical Oncology (ESMO) 2018 Annual Meeting Conference Call to be held at 4:30pm ET [...]
Devonian Health Group provides an update on its previously announced private placement
06/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. QUEBEC CITY, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ( “Devonian” or the “Corporation” ) (TSX VENTURE:GSD), a [...]
Groupe Santé Devonian fournit une mise à jour sur son placement privé préalablement annoncé
06/08/2018
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 06 août 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. ( « Devonian » ou la « Société » ) (TSX CROISSANCE:GSD), une société [...]
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
06/08/2018
EDISON, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Nohla Therapeutics Receives FDA Fast Track Designation for Dilanubicel for Allogeneic Cord Blood Transplant Patients
06/08/2018
SEATTLE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies for patients with hematologic malignancies and other critical diseases, today announced that [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2018
06/08/2018
Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 juillet 2018
06/08/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 juillet 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France [...]
Sanofi: Disclosure of trading in own shares
06/08/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
06/08/2018
Pièce jointe Reporting FR.pdf
VALNEVA : Déclaration d'actions et de droits de vote - JUILLET 2018
06/08/2018
Dénomination sociale : VALNEVA Adresse du siège social : 6 rue Alain Bombard, 44800 Saint-Herblain Marché réglementé Euronext Paris de Nyse Euronext - Compartiment B Date de la déclaration : Déclaration du 6 août 2018 [...]
ARM Foundation for Cell and Gene Medicine Releases Health Economic Impact Landscape Analysis Led by IQVIA
06/08/2018
Washington, D.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- The ARM Foundation for Cell and Gene Medicine (ARM Foundation) today released its first-of-its-kind Health Economic Impact Landscape Analysis of regenerative medicine [...]
Healthcare Administrative Technology Association (HATA) Publishes Industry Roadmap to Promote Interoperability and Reduce Health Care Costs
06/08/2018
LAGUNA BEACH, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- The Healthcare Administrative Technology Association (HATA), the national association representing the practice management systems (PMS) industry, recently [...]
Oryzon to present at upcoming international conferences
06/08/2018
Gordon Research Conference of “Neurobiology of Brain Disorders” in Barcelona (Spain) Solebury Trout 8th Annual Hamptons CEO Roundtable in Bridgehampton, USA MADRID, Spain and CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
06/08/2018
Villepinte (France), le 06 août 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur la [...]
Avinger to Report Second Quarter 2018 Results on Monday, August 13, 2018
06/08/2018
REDWOOD CITY, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), will announce its second quarter 2018 results for [...]
Paul Arnold, MD Offers Minimally Invasive HIFU Prostate Cancer Treatment in Greater Tampa Area
06/08/2018
HIFU, or high intensity focused ultrasound, is a non-invasive, outpatient, radiation-free treatment for prostate cancer CHARLOTTE, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC , the leading [...]
Cesca Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2018 and Host Conference Call on August 13
06/08/2018
RANCHO CORDOVA, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based [...]
Concierge Care Advisors Promotes Social Connections for Seniors with Seattle Mariners Ticket Giveaway
06/08/2018
CCA contest awards free tickets for resident seniors at local care facilities for an upcoming baseball game SEATTLE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Concierge Care Advisors , a pioneering senior care and housing [...]
Transactions under Novozymes’ stock buyback program
06/08/2018
Please read the full announcement in the attached PDF Attachment 2018_46_Stock_Buybackprogram_EN

Pages